UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6);ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
发明人:
Francis Berenbaum,Carole Bougault,Claire Attali
申请号：
US14424475
公开号：
US09592272B2
申请日:
2013.08.29
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to the use of the incretin hormones glucagon-like peptide-1 or GLP-1 and glucose-dependent insulinotropic polypeptide or GIP, or of analogs thereof, in particular the analogs resistant to dipeptidyl peptidase IV, in the treatment of osteoarthritis, in particular for inhibiting or slowing down cartilage destruction.
